Fitterfly raises series A funding

Fitterfly raises series A funding

EY successfully advised Fitterfly Healthtech Private Limited (“Fitterfly”) in raising Series A funding led by Amazon Smbhav Venture Fund and Fireside Ventures. 9 Unicorns, Venture Catalysts, 4point0 Health Ventures and other angel investors also participated in this round. This marks Amazon’s first health-tech deal in India.

EY acted as the exclusive financial advisor to Fitterfly. Founded in 2016 by Dr. Arbinder Singal and Shailesh Gupta, Fitterfly is amongst India’s largest and fastest growing digital therapeutics platform for diabetes, pregnancy, PCOS and obesity. Fitterfly has a patient base of 20,000+ with a prescribing network of 200+ doctors. The funds will be utilized for sales & marketing, enhancing the tech stack for improved clinical insights. 

Amazon Smbhav Venture Fund is a $250mn fund setup by Amazon to lead investments in start-ups. Fireside is amongst the leading consumer focused funds in India.

We are delighted to have advised Fitterfly on this milestone transaction. Fitterfly has completely revolutionized the approach to digital therapeutics through its highly advanced tech stack. With Amazon and Fireside’s investment, Fitterfly will further augment its capabilities in smart chronic disease management. This also marks Amazon’s first health-tech investment in India.